Medical - Healthcare Information Services
Compare Stocks
5 / 10Stock Comparison
EVH vs PINC vs ALHC vs HQY vs TDOC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Information Services
Medical - Healthcare Plans
Medical - Healthcare Information Services
Medical - Healthcare Information Services
EVH vs PINC vs ALHC vs HQY vs TDOC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Healthcare Information Services | Medical - Healthcare Plans | Medical - Healthcare Information Services | Medical - Healthcare Information Services |
| Market Cap | $488M | $2.34B | $3.73B | $7.14B | $1.26B |
| Revenue (TTM) | $1.89B | $1.00B | $4.26B | $1.31B | $2.51B |
| Net Income (TTM) | $-497M | $-24M | $20M | $215M | $-171M |
| Gross Margin | 14.0% | 72.6% | 9.0% | 69.5% | 65.6% |
| Operating Margin | -27.4% | -0.0% | 0.8% | 24.6% | -7.6% |
| Forward P/E | 31.2x | 20.8x | 140.9x | 21.2x | — |
| Total Debt | $990M | $282M | $338M | $44M | $1.04B |
| Cash & Equiv. | $152M | $84M | $578M | $319M | $781M |
EVH vs PINC vs ALHC vs HQY vs TDOC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | 100 | 21.2 | -78.8% |
| Premier, Inc. (PINC) | 100 | 83.1 | -16.9% |
| Alignment Healthcar… (ALHC) | 100 | 83.2 | -16.8% |
| HealthEquity, Inc. (HQY) | 100 | 123.5 | +23.5% |
| Teladoc Health, Inc. (TDOC) | 100 | 3.8 | -96.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EVH vs PINC vs ALHC vs HQY vs TDOC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EVH lags the leaders in this set but could rank higher in a more targeted comparison.
PINC carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 1 yrs, beta 0.07, yield 3.0%
- Beta 0.07, yield 3.0%, current ratio 0.64x
- Lower P/E (20.8x vs 21.2x)
- Beta 0.07 vs TDOC's 1.91, lower leverage
ALHC ranks third and is worth considering specifically for growth exposure.
- Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
- 46.1% revenue growth vs EVH's -26.6%
HQY is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 228.2% 10Y total return vs ALHC's 5.4%
- Lower volatility, beta 1.04, Low D/E 2.1%, current ratio 3.27x
- 16.4% margin vs EVH's -26.3%
- 6.3% ROA vs EVH's -22.8%, ROIC 10.2% vs -0.2%
Among these 5 stocks, TDOC doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 46.1% revenue growth vs EVH's -26.6% | |
| Value | Lower P/E (20.8x vs 21.2x) | |
| Quality / Margins | 16.4% margin vs EVH's -26.3% | |
| Stability / Safety | Beta 0.07 vs TDOC's 1.91, lower leverage | |
| Dividends | 3.0% yield, 1-year raise streak, vs EVH's 2.3%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +24.0% vs EVH's -59.0% | |
| Efficiency (ROA) | 6.3% ROA vs EVH's -22.8%, ROIC 10.2% vs -0.2% |
EVH vs PINC vs ALHC vs HQY vs TDOC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EVH vs PINC vs ALHC vs HQY vs TDOC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HQY leads in 2 of 6 categories
PINC leads 1 • EVH leads 0 • ALHC leads 0 • TDOC leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HQY leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ALHC is the larger business by revenue, generating $4.3B annually — 4.2x PINC's $1.0B. HQY is the more profitable business, keeping 16.4% of every revenue dollar as net income compared to EVH's -26.3%. On growth, ALHC holds the edge at +33.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.9B | $1.0B | $4.3B | $1.3B | $2.5B |
| EBITDAEarnings before interest/tax | -$403M | $118M | $66M | $322M | $42M |
| Net IncomeAfter-tax profit | -$497M | -$24M | $20M | $215M | -$171M |
| Free Cash FlowCash after capex | $1M | $265M | $237M | $439M | $251M |
| Gross MarginGross profit ÷ Revenue | +14.0% | +72.6% | +9.0% | +69.5% | +65.6% |
| Operating MarginEBIT ÷ Revenue | -27.4% | -0.0% | +0.8% | +24.6% | -7.6% |
| Net MarginNet income ÷ Revenue | -26.3% | -2.4% | +0.5% | +16.4% | -6.8% |
| FCF MarginFCF ÷ Revenue | +0.1% | +26.4% | +5.6% | +33.4% | +10.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.6% | -3.3% | +33.3% | +7.3% | -2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +61.9% | -70.0% | +2.1% | +93.3% | +32.1% |
Valuation Metrics
Evenly matched — EVH and TDOC each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 34.1x trailing earnings, HQY trades at a 73% valuation discount to PINC's 128.5x P/E. On an enterprise value basis, EVH's 11.9x EV/EBITDA is more attractive than ALHC's 77.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $488M | $2.3B | $3.7B | $7.1B | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $1.3B | $2.5B | $3.5B | $6.9B | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | -0.84x | 128.45x | -4932.43x | 34.14x | -6.11x |
| Forward P/EPrice ÷ next-FY EPS est. | 31.17x | 20.79x | 140.93x | 21.23x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.41x | — |
| EV / EBITDAEnterprise value multiple | 11.90x | 21.35x | 77.12x | 21.29x | 15.13x |
| Price / SalesMarket cap ÷ Revenue | 0.26x | 2.31x | 0.94x | 5.44x | 0.50x |
| Price / BookPrice ÷ Book value/share | 1.18x | 1.70x | 20.16x | 3.49x | 0.89x |
| Price / FCFMarket cap ÷ FCF | 102.63x | 7.33x | 32.95x | 15.69x | 4.40x |
Profitability & Efficiency
HQY leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
ALHC delivers a 11.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-78 for EVH. HQY carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to EVH's 2.38x. On the Piotroski fundamental quality scale (0–9), HQY scores 9/9 vs PINC's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -77.9% | -1.6% | +11.5% | +10.1% | -12.4% |
| ROA (TTM)Return on assets | -22.8% | -0.8% | +1.8% | +6.3% | -5.9% |
| ROICReturn on invested capital | -0.2% | +0.0% | — | +10.2% | -11.5% |
| ROCEReturn on capital employed | -0.3% | +0.0% | +2.9% | +9.8% | -10.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 6 | 9 | 6 |
| Debt / EquityFinancial leverage | 2.38x | 0.18x | 1.89x | 0.02x | 0.75x |
| Net DebtTotal debt minus cash | $838M | $198M | -$240M | -$275M | $259M |
| Cash & Equiv.Liquid assets | $152M | $84M | $578M | $319M | $781M |
| Total DebtShort + long-term debt | $990M | $282M | $338M | $44M | $1.0B |
| Interest CoverageEBIT ÷ Interest expense | -14.04x | 1.13x | 1.27x | 5.64x | -8.76x |
Total Returns (Dividends Reinvested)
Evenly matched — ALHC and HQY each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HQY five years ago would be worth $11,269 today (with dividends reinvested), compared to $461 for TDOC. Over the past 12 months, PINC leads with a +24.0% total return vs EVH's -59.0%. The 3-year compound annual growth rate (CAGR) favors ALHC at 36.2% vs EVH's -50.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +10.0% | — | -9.7% | -7.8% | -1.3% |
| 1-Year ReturnPast 12 months | -59.0% | +24.0% | +17.6% | -8.4% | +1.5% |
| 3-Year ReturnCumulative with dividends | -87.7% | +14.8% | +152.4% | +56.0% | -73.3% |
| 5-Year ReturnCumulative with dividends | -78.4% | -9.2% | -22.7% | +12.7% | -95.4% |
| 10-Year ReturnCumulative with dividends | -63.6% | -4.6% | +5.4% | +228.2% | -41.1% |
| CAGR (3Y)Annualised 3-year return | -50.2% | +4.7% | +36.2% | +16.0% | -35.6% |
Risk & Volatility
PINC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PINC is the less volatile stock with a 0.07 beta — it tends to amplify market swings less than TDOC's 1.91 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PINC currently trades 98.2% from its 52-week high vs EVH's 35.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.21x | 0.07x | 0.75x | 1.04x | 1.91x |
| 52-Week HighHighest price in past year | $12.07 | $28.79 | $23.87 | $116.65 | $9.77 |
| 52-Week LowLowest price in past year | $2.10 | $20.62 | $11.63 | $72.90 | $4.40 |
| % of 52W HighCurrent price vs 52-week peak | +35.5% | +98.2% | +76.5% | +72.0% | +71.2% |
| RSI (14)Momentum oscillator 0–100 | 68.0 | 65.0 | 37.3 | 52.7 | 74.1 |
| Avg Volume (50D)Average daily shares traded | 3.0M | 0 | 3.6M | 876K | 5.5M |
Analyst Outlook
Evenly matched — PINC and HQY each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EVH as "Buy", PINC as "Hold", ALHC as "Buy", HQY as "Buy", TDOC as "Hold". Consensus price targets imply 49.1% upside for EVH (target: $6) vs -0.0% for PINC (target: $28). For income investors, PINC offers the higher dividend yield at 2.98% vs EVH's 2.28%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $6.38 | $28.25 | $24.83 | $109.89 | $7.58 |
| # AnalystsCovering analysts | 29 | 31 | 16 | 27 | 42 |
| Dividend YieldAnnual dividend ÷ price | +2.3% | +3.0% | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | — | 2 | — |
| Dividend / ShareAnnual DPS | $0.10 | $0.84 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +8.2% | +17.1% | 0.0% | +4.2% | 0.0% |
HQY leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PINC leads in 1 (Risk & Volatility). 3 tied.
EVH vs PINC vs ALHC vs HQY vs TDOC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EVH or PINC or ALHC or HQY or TDOC a better buy right now?
For growth investors, Alignment Healthcare, Inc.
(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus -26. 6% for Evolent Health, Inc. (EVH). HealthEquity, Inc. (HQY) offers the better valuation at 34. 1x trailing P/E (21. 2x forward), making it the more compelling value choice. Analysts rate Evolent Health, Inc. (EVH) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EVH or PINC or ALHC or HQY or TDOC?
On trailing P/E, HealthEquity, Inc.
(HQY) is the cheapest at 34. 1x versus Premier, Inc. at 128. 5x. On forward P/E, Premier, Inc. is actually cheaper at 20. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — EVH or PINC or ALHC or HQY or TDOC?
Over the past 5 years, HealthEquity, Inc.
(HQY) delivered a total return of +12. 7%, compared to -95. 4% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: HQY returned +228. 2% versus EVH's -63. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EVH or PINC or ALHC or HQY or TDOC?
By beta (market sensitivity over 5 years), Premier, Inc.
(PINC) is the lower-risk stock at 0. 07β versus Teladoc Health, Inc. 's 1. 91β — meaning TDOC is approximately 2593% more volatile than PINC relative to the S&P 500. On balance sheet safety, HealthEquity, Inc. (HQY) carries a lower debt/equity ratio of 2% versus 2% for Evolent Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EVH or PINC or ALHC or HQY or TDOC?
By revenue growth (latest reported year), Alignment Healthcare, Inc.
(ALHC) is pulling ahead at 46. 1% versus -26. 6% for Evolent Health, Inc. (EVH). On earnings-per-share growth, the picture is similar: HealthEquity, Inc. grew EPS 125. 7% year-over-year, compared to -525. 9% for Evolent Health, Inc.. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EVH or PINC or ALHC or HQY or TDOC?
HealthEquity, Inc.
(HQY) is the more profitable company, earning 16. 4% net margin versus -28. 5% for Evolent Health, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HQY leads at 24. 6% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — PINC leads at 73. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EVH or PINC or ALHC or HQY or TDOC more undervalued right now?
On forward earnings alone, Premier, Inc.
(PINC) trades at 20. 8x forward P/E versus 140. 9x for Alignment Healthcare, Inc. — 120. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EVH: 49. 1% to $6. 38.
08Which pays a better dividend — EVH or PINC or ALHC or HQY or TDOC?
In this comparison, PINC (3.
0% yield), EVH (2. 3% yield) pay a dividend. ALHC, HQY, TDOC do not pay a meaningful dividend and should not be held primarily for income.
09Is EVH or PINC or ALHC or HQY or TDOC better for a retirement portfolio?
For long-horizon retirement investors, Premier, Inc.
(PINC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 07), 3. 0% yield). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PINC: -4. 6%, TDOC: -41. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EVH and PINC and ALHC and HQY and TDOC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EVH is a small-cap quality compounder stock; PINC is a small-cap quality compounder stock; ALHC is a small-cap high-growth stock; HQY is a small-cap quality compounder stock; TDOC is a small-cap quality compounder stock. EVH, PINC pay a dividend while ALHC, HQY, TDOC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.